News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Morosini Deborah
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/17/2022 |
4
| Morosini Deborah (EVP, Chief of Clinical Affairs) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Granted 90,000 options to buy
@ $10.58, valued at
$952.2k
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2021 |
4
| Morosini Deborah (EVP, Chief of Clinical Affairs) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Sold 28,351 shares
@ $15.8711, valued at
$450k
Sold 400 shares
@ $16.425, valued at
$6.6k
Exercised 28,751 options to buy
@ $12.85, valued at
$369.5k
|
|
| 07/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2020 |
4
| Morosini Deborah (EVP, Chief of Clinical Affairs) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Bought 444 shares
@ $19, valued at
$8.4k
|
|
| 09/24/2020 |
3
| Morosini Deborah (EVP, Chief of Clinical Affairs) has filed a Form 3 on Prelude Therapeutics Inc |
|
|